Immunoblotting of the separated membrane components of MiI erythrocytes with anti-Vw identified a band of M(r) 40,000 with a mobility close to that of β-sialoglycoprotein corresponding to the abnormal α-sialoglycoprotein present in Mil cells. A comparison of results obtained when MiIII erythrocytes were immunoblotted with anti-Mur, anti-s and the monoclonal antibody R1.3, indicated that the Mur antigen is located on the abnormal δ-sialoglycoprotein of Mr 36,000 in MiIII erythrocytes. Prior treatment of MiI erythrocytes with neuraminidase resulted in an increase in the intensity of staining of the anti-Vw reactive component. This was consistent with the enhanced reactions observed in haemagglutination tests with neuraminidase-treated erythrocytes. The mobility of the Vw component was reduced when erythrocytes were pre-treated with low concentrations of neuraminidase but increased when higher concentrations of neuraminidase were used.

This content is only available via PDF.
1991
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.